193 related articles for article (PubMed ID: 33684428)
1. Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate.
Shen Z; Wang Y; Xu H; Zhang Q; Sha C; Sun B; Li Q
Int J Biol Macromol; 2021 Jun; 180():494-509. PubMed ID: 33684428
[TBL] [Abstract][Full Text] [Related]
2. Site-Specific Glycan Microheterogeneity Evaluation of Aflibercept Fusion Protein by Glycopeptide-Based LC-MSMS Mapping.
Lee JY; Choi JW; Hwang S; Hahm SH; Ahn YH
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233110
[TBL] [Abstract][Full Text] [Related]
3. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y
MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS peptide mapping with automated data processing for routine profiling of N-glycans in immunoglobulins.
Shah B; Jiang XG; Chen L; Zhang Z
J Am Soc Mass Spectrom; 2014 Jun; 25(6):999-1011. PubMed ID: 24664809
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human lecithin-cholesterol acyltransferase Fc fusion: analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region.
Spahr C; Kim JJ; Deng S; Kodama P; Xia Z; Tang J; Zhang R; Siu S; Nuanmanee N; Estes B; Stevens J; Zhou M; Lu HS
Protein Sci; 2013 Dec; 22(12):1739-53. PubMed ID: 24115046
[TBL] [Abstract][Full Text] [Related]
6. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical Characterization, Glycosylation Pattern and Biosimilarity Assessment of the Fusion Protein Etanercept.
Montacir O; Montacir H; Springer A; Hinderlich S; Mahboudi F; Saadati A; Parr MK
Protein J; 2018 Apr; 37(2):164-179. PubMed ID: 29411222
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive N-Glycan Profiling of Cetuximab Biosimilar Candidate by NP-HPLC and MALDI-MS.
Liu S; Gao W; Wang Y; He Z; Feng X; Liu BF; Liu X
PLoS One; 2017; 12(1):e0170013. PubMed ID: 28072827
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Site-Specific Differences in Glycan Microheterogeneity by N-Glycopeptide Mapping of VEGFR-IgG Fusion Protein.
Hahm YH; Lee JY; Ahn YH
Molecules; 2019 Oct; 24(21):. PubMed ID: 31671706
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometry for protein sialoglycosylation.
Zhang Q; Li Z; Wang Y; Zheng Q; Li J
Mass Spectrom Rev; 2018 Sep; 37(5):652-680. PubMed ID: 29228471
[TBL] [Abstract][Full Text] [Related]
12. Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein products.
Tan Q; Guo Q; Fang C; Wang C; Li B; Wang H; Li J; Guo Y
MAbs; 2012; 4(6):761-74. PubMed ID: 23032066
[TBL] [Abstract][Full Text] [Related]
13. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.
Xie H; Chakraborty A; Ahn J; Yu YQ; Dakshinamoorthy DP; Gilar M; Chen W; Skilton SJ; Mazzeo JR
MAbs; 2010; 2(4):379-94. PubMed ID: 20458189
[TBL] [Abstract][Full Text] [Related]
14. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.
Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H
Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865
[TBL] [Abstract][Full Text] [Related]
15. Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites.
Alvarez-Manilla G; Atwood J; Guo Y; Warren NL; Orlando R; Pierce M
J Proteome Res; 2006 Mar; 5(3):701-8. PubMed ID: 16512686
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN
MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058
[TBL] [Abstract][Full Text] [Related]
17. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
Liu L
J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
[TBL] [Abstract][Full Text] [Related]
18. GPQuest: A Spectral Library Matching Algorithm for Site-Specific Assignment of Tandem Mass Spectra to Intact N-glycopeptides.
Toghi Eshghi S; Shah P; Yang W; Li X; Zhang H
Anal Chem; 2015; 87(10):5181-8. PubMed ID: 25945896
[TBL] [Abstract][Full Text] [Related]
19. Multiple enzyme approach for the characterization of glycan modifications on the C-terminus of the intestinal MUC2mucin.
van der Post S; Thomsson KA; Hansson GC
J Proteome Res; 2014 Dec; 13(12):6013-23. PubMed ID: 25406038
[TBL] [Abstract][Full Text] [Related]
20. A rapid method for relative quantification of
Segu Z; Stone T; Berdugo C; Roberts A; Doud E; Li Y
MAbs; 2020; 12(1):1750794. PubMed ID: 32249667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
